| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.97▲ | 1.99▼ | 1.99▼ | 1.81▲ | 1.50▲ |
| MA10 | 1.98▲ | 2.00▼ | 1.98▼ | 1.70▲ | 1.54▲ |
| MA20 | 1.98▼ | 1.97▲ | 1.88▲ | 1.49▲ | 1.12▲ |
| MA50 | 1.99▼ | 1.85▲ | 1.75▲ | 1.45▲ | 0.72▲ |
| MA100 | 1.98▲ | 1.74▲ | 1.58▲ | 1.06▲ | 1.14▲ |
| MA200 | 1.88▲ | 1.55▲ | 1.53▲ | 0.74▲ | 2.90▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | -0.009▼ | 0.001▲ | 0.054▲ | 0.056▲ |
| RSI | 48.566▼ | 58.902▲ | 67.052▲ | 65.614▲ | 72.646▲ |
| STOCH | 32.365 | 46.338 | 69.217 | 84.901▲ | 56.491 |
| WILL %R | -45.455 | -53.846 | -19.718▲ | -8.755▲ | -8.039▲ |
| CCI | -27.339 | -115.310▼ | 33.786 | 155.432▲ | 118.294▲ |
|
Thursday, May 16, 2024 09:31 AM
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. This press release may be considered Attorney ...
|
|
Wednesday, May 15, 2024 09:00 PM
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focusing on innovative therapies, announced the completion of dosing in the second cohort of its groundbreaking GARDian clinical ...
|
|
Wednesday, May 15, 2024 05:00 PM
Ocugen Has Dosed The First Patient In The Armada Phase 1/2 Trial Of OCU410 (AAV-RORA), A Modifier Gene Therapy Product Candidate Being Developed For Dry Age-related Macular Degeneration ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 16/05/24 | 1.955 | 2.05 | 1.92 | 1.98 | 9,372,783 |
| 15/05/24 | 1.74 | 2.00 | 1.69 | 1.96 | 15,613,622 |
| 14/05/24 | 1.69 | 1.82 | 1.6412 | 1.70 | 8,835,124 |
| 13/05/24 | 1.64 | 1.82 | 1.64 | 1.805 | 10,048,534 |
| 10/05/24 | 1.67 | 1.6897 | 1.54 | 1.59 | 4,735,691 |
| 09/05/24 | 1.70 | 1.715 | 1.615 | 1.67 | 5,386,123 |
| 08/05/24 | 1.56 | 1.75 | 1.51 | 1.72 | 10,308,209 |
| 07/05/24 | 1.60 | 1.71 | 1.51 | 1.57 | 6,477,776 |
| 06/05/24 | 1.34 | 1.65 | 1.33 | 1.63 | 13,437,004 |
| 03/05/24 | 1.36 | 1.42 | 1.32 | 1.33 | 4,822,158 |
|
|
||||
|
|
||||
|
|